In human brain tumours, BRAF V600E mutations are seen in 5% of posterior fossa pilocytic astrocytomas, approximately one third of gangliogliomas and nearly 70% of pleomorphic xanthoastrocytomas, and a small proportion of glioblastomas. This evidence concerns the gene BRAF and glioblastoma.